Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of orexin-1 receptor signaling in demand for the opioid fentanyl
Jennifer E. Fragale, Caroline B. Pantazis, Morgan H. James, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 10, pp. 1690-1697
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 179
The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies
Ying Han, Wei Yan, Yongbo Zheng, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 169
Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 65
Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System
Linnea R. Freeman, Brandon S. Bentzley, Morgan H. James, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 54-63
Open Access | Times Cited: 59
Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Binge eating, overeating and food addiction: Approaches for examining food overconsumption in laboratory rodents
Robyn M. Brown, Morgan H. James
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 123, pp. 110717-110717
Open Access | Times Cited: 19
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil
Aida Mohammadkhani, Jennifer E. Fragale, Caroline B. Pantazis, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 49, pp. 9831-9840
Open Access | Times Cited: 52
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Sleep loss and addiction
Luis Angel López-Muciño, Fabio Garcı́a-Garcı́a, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Genetic associations between orexin genes and phenotypes related to behavioral regulation in humans, including substance use
Fazil Alıev, David De Sa Nogueira, Gary Aston‐Jones, et al.
Molecular Psychiatry (2025)
Open Access
Chronic but not acute morphine exposure reversibly impairs spike generation and repetitive firing in a functionally distinct subpopulation of orexin neurons
Emma Berry, Ellen N. Huhulea, Masaru Ishibashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access
Hypothesizing glucagon-like peptide 1 (GLP-1), agonists promote hypodopaminergia, resulting in heightened addictive reward-seeking and altered mood: Breaking the bubble and adding salt to a wound
Kenneth Blum, Catherine A. Dennen, Kai-Uwe Lewandrowski, et al.
Medical Hypotheses (2025), pp. 111612-111612
Closed Access
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration
Sam A. McConnell, Adam J. Brandner, Brandon A. Blank, et al.
Neuropharmacology (2020) Vol. 182, pp. 108355-108355
Open Access | Times Cited: 32
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Ying Han, Lu Cao, Kai Yuan, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 11, pp. 1365-1382
Open Access | Times Cited: 19
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Glenn Pascasio, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 647-660
Closed Access | Times Cited: 4
Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
Igor Elman, Margaret Howard, Jacob T. Borodovsky, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Effects of 5‐HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self‐administration in male rats
David Martin, Utsav Gyawali, Donna J. Calu
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 30
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine
Caroline B. Pantazis, Morgan H. James, Shayna L. O’Connor, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 3, pp. 741-751
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top